{"id":55152,"date":"2023-03-23T21:04:56","date_gmt":"2023-03-23T20:04:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/"},"modified":"2023-03-23T21:04:56","modified_gmt":"2023-03-23T20:04:56","slug":"better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/","title":{"rendered":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc<\/a>. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its fourth quarter and full year 2022 financial results before the market opens on Thursday, March 30, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET \/ 5:30 a.m. PT on Thursday, March 30, 2023.\n<\/p>\n

<\/a><\/p>\n

\nTo access the conference call, please register at: https:\/\/register.vevent.com\/register\/BI24e91f91597f4f97a40e32c908ac7be5<\/a>. Upon registering, each participant will be provided with call details and access codes. All participants are encouraged to join 10 minutes prior to the start time. The live webcast may be accessed by visiting the event link at: https:\/\/edge.media-server.com\/mmc\/p\/cmdsh8s3<\/a>. Following the webcast, a replay of the webcast may be accessed from the Presentations & Events page in the Investors section of the Better Therapeutics corporate website at: investors.bettertx.com<\/a>.\n<\/p>\n

\nAbout Better Therapeutics<\/b>\n<\/p>\n

\nBetter Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The CBT delivered by Better Therapeutics\u2019 PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics\u2019 clinically validated mobile applications, if authorized for marketing, are intended to be prescribed by physicians and reimbursed like traditional medicines.\n<\/p>\n

\nFor more information visit: bettertx.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Mark Heinen
\n
IR@bettertx.com<\/a>\n<\/p>\n

\nMedia Enquiries:<\/b>
Emma Williams
\n
emma.williams@bettertx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its fourth quarter and full year 2022 financial results before the market opens on Thursday, March 30, 2023. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55152","6":"format-standard","7":"category-industry"},"yoast_head":"\nBetter Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its fourth quarter and full year 2022 financial results before the market opens on Thursday, March 30, 2023. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-23T20:04:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023\",\"datePublished\":\"2023-03-23T20:04:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/\"},\"wordCount\":330,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005693\\\/en\\\/1746369\\\/21\\\/Better_Tx_640x360_Logo_%28002%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/\",\"name\":\"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005693\\\/en\\\/1746369\\\/21\\\/Better_Tx_640x360_Logo_%28002%29.jpg\",\"datePublished\":\"2023-03-23T20:04:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005693\\\/en\\\/1746369\\\/21\\\/Better_Tx_640x360_Logo_%28002%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230323005693\\\/en\\\/1746369\\\/21\\\/Better_Tx_640x360_Logo_%28002%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its fourth quarter and full year 2022 financial results before the market opens on Thursday, March 30, 2023. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-23T20:04:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023","datePublished":"2023-03-23T20:04:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/"},"wordCount":330,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/","url":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/","name":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg","datePublished":"2023-03-23T20:04:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230323005693\/en\/1746369\/21\/Better_Tx_640x360_Logo_%28002%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/better-therapeutics-to-release-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55152"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55152\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}